russjcardiolРоссийский кардиологический журналRussian Journal of Cardiology1560-40712618-7620«SILICEA-POLIGRAF» LLC10.15829/1560-4071-2022-5235russjcardiol-5235Research ArticleОБЗОРЫ ЛИТЕРАТУРЫREVIEWМишени для профилактики коморбидности сердечно-сосудистых и онкологических заболеванийTargets for the prevention of comorbidity of cardiovascular and cancer diseaseshttps://orcid.org/0000-0001-7131-8049МамедовМ. Н.MamedovM. N.

Мамедов Мехман Н. — доктор медицинских наук, профессор, руководитель отдела вторичной профилактики ХНИЗ.

Москва

mmamedov@gnicpm.ruhttps://orcid.org/0000-0001-7025-3466БадейниковаК. К.BadeinikovaK. K.

Младший научный сотрудник отдела вторичной профилактики ХНИЗ.

Москва

Moscow

https://orcid.org/0000-0002-7031-7033КаримовА. К.KarimovA. K.

Соискатель отдела вторичной профилактики ХНИЗ.

Москва

Moscow

ФГБУ Национальный медицинский исследовательский центр терапии и профилактической медицины Минздрава РоссииРоссияNational Medical Research Center for Therapy and Preventive MedicineRussian Federation202208122022271152355235Copyright © Мамедов М.Н., Бадейникова К.К., Каримов А.К., 20222022Мамедов М.Н., Бадейникова К.К., Каримов А.К.Mamedov M.N., Badeinikova K.K., Karimov A.K.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://russjcardiol.elpub.ru/jour/article/view/5235

Сердечно-сосудистые заболевания и онкологические заболевания являются актуальной проблемой в медицине, что обусловлено их высокой распространенностью и прогнозом в летальности взрослых лиц во всем мире. В обзорной статье рассматриваются важные аспекты коморбидности сердечно-сосудистых и онкологических заболеваний. В частности, проанализированы эпидемиологические аспекты и общие факторы риска. Представлены современные взгляды с точки зрения профессиональных обществ на основные вопросы первичной и вторичной профилактики сочетания этих заболеваний.

Cardiovascular and cancer diseases are an urgent problem in medicine due to their high prevalence and adult mortality throughout the world. The review article discusses important aspects of the comorbidity of cardiovascular and cancer diseases. In particular, epidemiological aspects and general risk factors are analyzed. Modern view on the main issues of primary and secondary prevention of the combination of these diseases is presented.

факторы рискасердечно-сосудистые заболеванияонкологические заболеванияпервичная профилактикакоморбидностьrisk factorscardiovascular diseasescancerprimary preventioncomorbidityReferencesGBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1223-49. doi:10.1016/S0140-6736(20)30752-2.GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1223-49. doi:10.1016/S0140-6736(20)30752-2.Puska P, Laatikainen T, Korpelainen V, Vartiainen E. Contribution of the North Karelia Project to International Work in CVD and NCD Prevention and Health Promotion. Glob Heart. 2016;11(2):243-6. doi:10.1016/j.gheart.2016.04.009.Puska P, Laatikainen T, Korpelainen V, Vartiainen E. Contribution of the North Karelia Project to International Work in CVD and NCD Prevention and Health Promotion. Glob Heart. 2016;11(2):243-6. doi:10.1016/j.gheart.2016.04.009.Malta DC, Silva MMAD. Noncommunicable Chronic Diseases: the contemporary challenge in Public Health. Cien Saude Colet. 2018;23(5):1350. doi:10.1590/1413-81232018235.31552017.Malta DC, Silva MMAD. Noncommunicable Chronic Diseases: the contemporary challenge in Public Health. Cien Saude Colet. 2018;23(5):1350. doi:10.1590/1413-81232018235.31552017.Health care in Russia. 2019: Stat.sb./Rosstat. M., Z-46 2019. 170 p. (In Russ.) Здравоохранение в России. 2019: Стат.сб./Росстат. М., З-46 2019. 170 с. ISBN 978-5-89476-470-2.Health care in Russia. 2019: Stat.sb./Rosstat. M., Z-46 2019. 170 p. (In Russ.) ISBN 978-5-89476-470-2.Каприн А. Д., Старинский В. В., Шахзадова А. О. Злокачественные новообразования в России в 2019 году (заболеваемость и смертность) М.: МНИОИ им. П. А. Герцена — филиал ФГБУ "НМИЦ радиологии" Минздрава России, 2020. илл. 252 с. ISBN 978-5-85502-260-5.Kaprin AD, Starinsky VV, Shakhzadova AO. Malignant neoplasms in Russia in 2019 (morbidity and mortality) M.: MNIOI im. P. A. Herzen branch of the Federal State Budgetary Institution "NMITs Radiology" of the Ministry of Health of Russia, 2020. — ill. 252 pp. (In Russ.) ISBN 978-5-85502-260-5.Freisling H, Viallon V, Lennon H, et al. Lifestyle factors and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study. BMC Med. 2020; 18(1):5. doi:10.1186/s12916-019-1474-7.Freisling H, Viallon V, Lennon H, et al. Lifestyle factors and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study. BMC Med. 2020; 18(1):5. doi:10.1186/s12916-019-1474-7.Weaver KE, Foraker RE, Alfano CM, et al. Cardiovascular risk factors among long-term survivors of breast, prostate, colorectal, and gynecologic cancers: a gap in survivorship care? J Cancer Surviv. 2013;7(2):253-61. doi:10.1007/s11764-013-0267-9.Weaver KE, Foraker RE, Alfano CM, et al. Cardiovascular risk factors among long-term survivors of breast, prostate, colorectal, and gynecologic cancers: a gap in survivorship care? J Cancer Surviv. 2013;7(2):253-61. doi:10.1007/s11764-013-0267-9.Dutkowska AE, Antczak A. Comorbidities in lung cancer. Pneumonol Alergol Pol. 2016;84(3):186-92. doi:10.5603/PiAP.2016.0022.Dutkowska AE, Antczak A. Comorbidities in lung cancer. Pneumonol Alergol Pol. 2016;84(3):186-92. doi:10.5603/PiAP.2016.0022.Мамедов М. Н., Потиевская В. И., Сарибекян Э. К. и др. Хронические неинфекционные заболевания, факторы риска и качество жизни лиц со злокачественной опухолью разной локализации. Профилактическая медицина. 2021;24(11):45-51. doi:10.17116/profmed20212411145.Mamedov MN, Potievskaya VI, Saribekyan EK, et al. Chronic non-communicable diseases, risk factors, and quality of life in patients with malignancies of various localizations. Profilakticheskaya Meditsina. 2021;24(11):45-51. (In Russ.) doi:10.17116/profmed20212411145.Драпкина О. М., Шутов А. М., Ефремова Е. В. Коморбидность, мультиморбидность, двойной диагноз — синонимы или разные понятия? Кардиоваскулярная терапия и профилактика. 2019;18(2):65-9. doi:10.15829/1728-8800-2019-2-65-69.Drapkina OM, Shutov AM, Efremova EV. Comorbidity, multimorbidity, dual diagnosis — synonyms or different terms? Cardiovascular Therapy and Prevention. 2019;18(2):65-9. (In Russ.) doi:10.15829/1728-8800-2019-2-65-69.Толпыгина С. Н., Марцевич С. Ю., Деев А. Д. Влияние сопутствующих заболеваний на отдаленной прогноз пациентов с хронической ишемической болезнью сердца по данным регистра "ПРОГНОЗ ИБС". Рациональная Фармакотерапия в Кардиологии. 2015;11(6):571-6. doi:10.20996/1819-6446-2015-11-6-571-576.Tolpygina SN, Martsevich SYu, Deev AD. The influence of concomitant diseases on a long-term prognosis in patients with chronic ischemic heart disease according to the PROGNOZ IBS register. Rational Pharmacotherapy in Cardiology. 2015;11(6):571-6. (In Russ.) doi:10.20996/1819-6446-2015-11-6-571-576.Feng J, Mu X-M, Ma L-L, Wang W. Comorbidity Patterns of Older Lung Cancer Patients in Northeast China: An Association Rules Analysis Based on Electronic Medical Records. Int J Environ Res Public Health. 2020;17(23):9119. doi:10.3390/ijerph17239119.Feng J, Mu X-M, Ma L-L, Wang W. Comorbidity Patterns of Older Lung Cancer Patients in Northeast China: An Association Rules Analysis Based on Electronic Medical Records. Int J Environ Res Public Health. 2020;17(23):9119. doi:10.3390/ijerph17239119.Koné AP, Scharf D. Prevalence of multimorbidity in adults with cancer, and associated health service utilization in Ontario, Canada: a population-based retrospective cohort study. BMC Cancer. 2021;21(1):406. doi:10.1186/s12885-021-08102-1.Koné AP, Scharf D. Prevalence of multimorbidity in adults with cancer, and associated health service utilization in Ontario, Canada: a population-based retrospective cohort study. BMC Cancer. 2021;21(1):406. doi:10.1186/s12885-021-08102-1.Liu D, Ma Z, Yang J, et al. Prevalence and prognosis significance of cardiovascular disease in cancer patients: a population-based study. Aging (Albany NY). 2019;11(18):7948-60. doi:10.18632/aging.102301.Liu D, Ma Z, Yang J, et al. Prevalence and prognosis significance of cardiovascular disease in cancer patients: a population-based study. Aging (Albany NY). 2019;11(18):7948-60. doi:10.18632/aging.102301.Sadeer G Al-Kindi, Guilherme H Oliveira. Prevalence of Preexisting Cardiovascular Disease in Patients With Different Types of Cancer: The Unmet Need for Onco-Cardiology. Mayo Clin Proc. 2016;91(1):81-3. doi:10.1016/j.mayocp.2015.09.009.Sadeer G Al-Kindi, Guilherme H Oliveira. Prevalence of Preexisting Cardiovascular Disease in Patients With Different Types of Cancer: The Unmet Need for Onco-Cardiology. Mayo Clin Proc. 2016;91(1):81-3. doi:10.1016/j.mayocp.2015.09.009.Buddeke J, Bots ML, van Dis I, et al. Trends in comorbidity in patients hospitalised for cardiovascular disease. Int J Cardiol. 2017;248:382-8.Buddeke J, Bots ML, van Dis I, et al. Trends in comorbidity in patients hospitalised for cardiovascular disease. Int J Cardiol. 2017;248:382-8.Koene RJ, Prizment AE, Blaes A, Konety SH. Shared Risk Factors in Cardiovascular Disease and Cancer. Circulation. 2016;133(11):1104-14. doi:10.1161/CIRCULATIONAHA.115.020406.Koene RJ, Prizment AE, Blaes A, Konety SH. Shared Risk Factors in Cardiovascular Disease and Cancer. Circulation. 2016;133(11):1104-14. doi:10.1161/CIRCULATIONAHA.115.020406.Sunghwan Suh, Kwang Won Kim. Diabetes and Cancer: Cancer Should Be Screened in Routine Diabetes Assessment. Diabetes Metab J. 2019;43(6):733-43. doi:10.4093/dmj.2019.0177.Sunghwan Suh, Kwang Won Kim. Diabetes and Cancer: Cancer Should Be Screened in Routine Diabetes Assessment. Diabetes Metab J. 2019;43(6):733-43. doi:10.4093/dmj.2019.0177.Carr LL, Jacobson S, Lynch DA, et al. Features of COPD as Predictors of Lung Cancer. Chest. 2018;153(6):1326-35. doi:10.1016/j.chest.2018.01.049.Carr LL, Jacobson S, Lynch DA, et al. Features of COPD as Predictors of Lung Cancer. Chest. 2018;153(6):1326-35. doi:10.1016/j.chest.2018.01.049.Yang F, Xu Y-L, Zhu R-F. Helicobacter pylori infection and the risk of colorectal carcinoma: a systematic review and meta-analysis. Minerva Med. 2019;110(5):464-70. doi:10.23736/S0026-4806.19.05942-1.Yang F, Xu Y-L, Zhu R-F. Helicobacter pylori infection and the risk of colorectal carcinoma: a systematic review and meta-analysis. Minerva Med. 2019;110(5):464-70. doi:10.23736/S0026-4806.19.05942-1.Curigliano G, Lenihan D, Fradley M, et al. Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations. Ann Oncol. 2020;31(2):171-90. doi:10.1016/j.annonc.2019.10.023.Curigliano G, Lenihan D, Fradley M, et al. Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations. Ann Oncol. 2020;31(2):171-90. doi:10.1016/j.annonc.2019.10.023.Васюк Ю. А., Гендлин Г. Е., Емелина Е. И. и др. Согласованное мнение Российских экспертов по профилактике, диагностике и лечению сердечно-сосудистой токсичности противоопухолевой терапии. Российский кардиологический журнал. 2021;26(9):4703. doi:10.15829/1560-4071-2021-4703.Vasyuk YuA, Gendlin GE, Emelina EI, et al. Сonsensus statement of Russian experts on the prevention, diagnosis and treatment of cardiotoxicity of anticancer therapy. Russian Journal of Cardiology. 2021;26(9):4703. (In Russ.) doi:10.15829/1560-4071-2021-4703.Mellemgaard A, Lüchtenborg M, Iachina M, et al. Role of comorbidity on survival after radiotherapy and chemotherapy for nonsurgically treated lung cancer. J Thorac Oncol. 2015;10:272-9. doi:10.1097/JTO.0000000000000416.Mellemgaard A, Lüchtenborg M, Iachina M, et al. Role of comorbidity on survival after radiotherapy and chemotherapy for nonsurgically treated lung cancer. J Thorac Oncol. 2015;10:272-9. doi:10.1097/JTO.0000000000000416.Bendor CD, Bardugo A, Pinhas-Hamiel O, et al. Cardiovascular morbidity, diabetes and cancer risk among children and adolescents with severe obesity. Cardiovasc Diabetol. 2020;19(1):79. doi:10.1186/s12933-020-01052-1.Bendor CD, Bardugo A, Pinhas-Hamiel O, et al. Cardiovascular morbidity, diabetes and cancer risk among children and adolescents with severe obesity. Cardiovasc Diabetol. 2020;19(1):79. doi:10.1186/s12933-020-01052-1.Стародубов В. И., Сон И. М., Сененко А. Ш. и соавторы. Итоги диспансеризации определенных групп взрослого населения Российской федерации 2013-2018 гг. Информационно-аналитический обзор. Москва. РИО ЦНИИОИЗ МЗ РФ. 2019; 114 с.Starodubov VI, Son IM, Senenko Ash, et al. The results of medical examination of certain groups of the adult population of the Russian Federation in 2013-2018 Informationanalytical review. Moscow. RIO TsNIIOIZ of the Ministry of Health of the Russian Federation, 2019. 114 p. (In Russ.)Götze H, Taubenheim S, Dietz A, et al. Comorbid conditions and health-related quality of life in long-term cancer survivors-associations with demographic and medical characteristics. J Cancer Surviv. 2018;12(5):712-20. doi:10.1007/s11764-018-0708-6.Götze H, Taubenheim S, Dietz A, et al. Comorbid conditions and health-related quality of life in long-term cancer survivors-associations with demographic and medical characteristics. J Cancer Surviv. 2018;12(5):712-20. doi:10.1007/s11764-018-0708-6.

The authors declare that there are no conflicts of interest present.